Know Cancer

or
forgot password

Effectiveness of a Resistance Training Program on Inflammatory Markers and Chemotherapy Completion in Lung Cancer Patients on Chemotherapy


N/A
21 Years
N/A
Not Enrolling
Both
Inflammation, Lung Cancer

Thank you

Trial Information

Effectiveness of a Resistance Training Program on Inflammatory Markers and Chemotherapy Completion in Lung Cancer Patients on Chemotherapy


Inclusion Criteria:



- Histologically diagnosed with lung cancer

- Stage I, II, or III

- Eligible for chemotherapy with curative intent

- 21 years of age or older

- Approval to participate in study by treating oncologist or family physician

Exclusion Criteria:

- Unstable cardiac disease

- Untreated bone or brain metastases

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Systemic inflammation measured by c-reactive protein.

Outcome Time Frame:

12 weeks

Safety Issue:

No

Principal Investigator

Kristina H Karvinen, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

East Carolina University

Authority:

United States: Institutional Review Board

Study ID:

UMCIRB 09-0725

NCT ID:

NCT01130714

Start Date:

January 2010

Completion Date:

July 2012

Related Keywords:

  • Inflammation
  • Lung Cancer
  • inflammation
  • chemotherapy
  • lung cancer
  • Inflammation
  • Lung Neoplasms

Name

Location
Leo Jenkins Cancer Center Greenville, North Carolina  28734